SCHEMBL6428246

SCHEMBL6428246

O=C1C(c2ccncn2)=C(C(F)(F)F)C(=O)N1Cc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.39
NR1H2 P55055 2/20 0.38
NR1H3 Q13133 2/20 0.38
CYP2D6 P10635 1/20 0.38
CASP3 P42574 1/20 0.37
SIRT2 Q8IXJ6 1/20 0.36
F2 P00734 1/20 0.36
PLG P00747 1/20 0.36
ELANE P08246 1/20 0.36
CTSG P08311 1/20 0.36
CMA1 P23946 1/20 0.36
CTRC Q99895 1/20 0.36
P2RX7 Q99572 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
NPSR1 Q6W5P4 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6429546 0.86 OPRK1 (0.40) GSK3BNR1H2NR1H3CASP3SIRT2
SCHEMBL6429956 0.82 MAPT (0.43) GSK3BNR1H2NR1H3CASP3SIRT2
SCHEMBL6426783 0.82 NR1H2 (0.47) GSK3BNR1H2NR1H3CASP3SIRT2
SCHEMBL6427487 0.77 DHPS (0.46) NR1H2NR1H3CYP2D6KDM4EALDH1A1
SCHEMBL6428548 0.73 NR1H2 (0.56) GSK3BNR1H2NR1H3CASP3SIRT2
SCHEMBL6429398 0.72 NPSR1 (0.41) GSK3BNR1H2NR1H3CASP3SIRT2
SCHEMBL6427166 0.71 CASP1 (0.47) NR1H2NR1H3CASP3MAPTMEN1
SCHEMBL6525603 0.69 NR1H2 (0.41) NR1H2NR1H3CASP3SIRT2F2
SCHEMBL6429024 0.68 PTGS2 (0.46) NR1H2NR1H3
SCHEMBL6442280 0.67 MAPT (0.46) GSK3BNR1H2NR1H3CASP3SIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005024755-A2 MEDICAMENTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS OR DIABETES DECIPHERA PHARMACEUTICALS, LLC. (US) 2005-03-17 WO disclosed